STAT - Reporting from the frontiers of health and medicine

First Opinion

By Andy Harris, Greg Murphy, and Mariannette Miller-Meeks

Adam's Take

Health

Politics Senate approves $1.9 trillion coronavirus relief bill
Health The short-term, middle-term, and long-term future of the coronavirus
Biotech What to look for in Lilly’s eagerly awaited Alzheimer’s data
Special Report In Palm Beach, Covid-19 vaccines intended for rural Black communities are instead going to wealthy white Floridians
In the Lab ‘We’re only going to cure diseases if we understand them’: Whitehead director advocates for basic science

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Lawmakers rail against huge tax breaks drug wholesalers get from opioid settlement
European Commission probes Teva for allegedly using patents to thwart competition
Up and down the ladder: The latest comings and goings

STAT Madness

By STAT staff

A STAT Investigation

First Opinion Podcast

In Memoriam

Special Report

Exclusive

Health Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson
Health The short-term, middle-term, and long-term future of the coronavirus
STAT Madness STAT Madness has begun. Vote for the best innovations in biomedicine
Special Report The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
First Opinion Federal law prohibits employers and others from requiring vaccination with a Covid-19 vaccine distributed under an EUA
Health The Covid-19 Tracker
Health ‘This isn’t done’: Experts warn that no matter what our Covid end goal is, we have a ways to go
Health FDA authorizes new test, built with machine learning, to detect past Covid-19 infections